GB9013410D0 - Polypeptide and its use - Google Patents

Polypeptide and its use

Info

Publication number
GB9013410D0
GB9013410D0 GB909013410A GB9013410A GB9013410D0 GB 9013410 D0 GB9013410 D0 GB 9013410D0 GB 909013410 A GB909013410 A GB 909013410A GB 9013410 A GB9013410 A GB 9013410A GB 9013410 D0 GB9013410 D0 GB 9013410D0
Authority
GB
United Kingdom
Prior art keywords
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB909013410A
Other versions
GB2246569A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHARING CROSS SUNLEY RESEARCH
Original Assignee
CHARING CROSS SUNLEY RESEARCH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHARING CROSS SUNLEY RESEARCH filed Critical CHARING CROSS SUNLEY RESEARCH
Priority to GB9013410A priority Critical patent/GB2246569A/en
Publication of GB9013410D0 publication Critical patent/GB9013410D0/en
Publication of GB2246569A publication Critical patent/GB2246569A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
GB9013410A 1990-06-15 1990-06-15 Tumour necrosis factor - alpha binding protein Withdrawn GB2246569A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9013410A GB2246569A (en) 1990-06-15 1990-06-15 Tumour necrosis factor - alpha binding protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9013410A GB2246569A (en) 1990-06-15 1990-06-15 Tumour necrosis factor - alpha binding protein

Publications (2)

Publication Number Publication Date
GB9013410D0 true GB9013410D0 (en) 1990-08-08
GB2246569A GB2246569A (en) 1992-02-05

Family

ID=10677692

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9013410A Withdrawn GB2246569A (en) 1990-06-15 1990-06-15 Tumour necrosis factor - alpha binding protein

Country Status (1)

Country Link
GB (1) GB2246569A (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL98078A0 (en) * 1991-05-07 1992-06-21 Yeda Res & Dev Pharmaceutical compositions comprising an anticytokyne
US5512544A (en) * 1987-09-13 1996-04-30 Yeda Research And Development Co. Ltd. Pharmaceutical compositions comprising an anticytokine
US7264944B1 (en) 1989-04-21 2007-09-04 Amgen Inc. TNF receptors, TNF binding proteins and DNAs coding for them
DE59010941D1 (en) 1989-04-21 2005-03-24 Amgen Inc TNF receptor, TNF-binding proteins and DNAs coding therefor
US6221675B1 (en) 1989-04-21 2001-04-24 Amgen, Inc. TNF receptors, TNF binding proteins and DNAs coding for them
IL95031A (en) 1989-07-18 2007-03-08 Amgen Inc Method for the production of a human recombinant tumor necrosis factor inhibitor
US6143866A (en) * 1989-07-18 2000-11-07 Amgen, Inc. Tumor necrosis factor (TNF) inhibitor and method for obtaining the same
EP0417563B1 (en) 1989-09-12 2000-07-05 F. Hoffmann-La Roche Ag TNF-binding proteins
US6552170B1 (en) 1990-04-06 2003-04-22 Amgen Inc. PEGylation reagents and compounds formed therewith
WO1993006128A1 (en) * 1991-09-16 1993-04-01 Peptide Technology Limited Tnf antagonist peptides
US6270766B1 (en) 1992-10-08 2001-08-07 The Kennedy Institute Of Rheumatology Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease
TW555765B (en) 1996-07-09 2003-10-01 Amgen Inc Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
CA2273850A1 (en) 1996-12-06 1998-06-11 Amgen Inc. Combination therapy using a tnf binding protein for treating tnf-mediated diseases
EP2002846B1 (en) 1996-12-06 2017-01-25 Amgen Inc. Combination therapy using an IL-1 inhibitor for treating IL-1 mediated diseases
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
NZ530765A (en) 2001-06-26 2006-11-30 Amgen Fremont Inc Antibodies that bind OPGL and compositions and methods for the treatment of bone diseases
WO2003011323A1 (en) * 2001-07-30 2003-02-13 Genset S.A. Agonists and antagonists of contabix for use in the treatment of metabolic disorders
US9028822B2 (en) 2002-06-28 2015-05-12 Domantis Limited Antagonists against TNFR1 and methods of use therefor
JP2006517191A (en) 2002-12-30 2006-07-20 アムジエン・インコーポレーテツド Combination therapy using costimulatory factors
US7833527B2 (en) 2006-10-02 2010-11-16 Amgen Inc. Methods of treating psoriasis using IL-17 Receptor A antibodies
TW201117824A (en) 2009-10-12 2011-06-01 Amgen Inc Use of IL-17 receptor a antigen binding proteins
US20140234330A1 (en) 2011-07-22 2014-08-21 Amgen Inc. Il-17 receptor a is required for il-17c biology
KR102530900B1 (en) 2014-03-31 2023-05-12 암젠 케이-에이, 인크. Methods of treating nail and scalp psoriasis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59010941D1 (en) * 1989-04-21 2005-03-24 Amgen Inc TNF receptor, TNF-binding proteins and DNAs coding therefor
US5395760A (en) * 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
DE69022559T2 (en) * 1989-12-13 1996-05-02 Yeda Res & Dev Expression of the recombinant tumor necrosis factor binding protein I (TBP-I).

Also Published As

Publication number Publication date
GB2246569A (en) 1992-02-05

Similar Documents

Publication Publication Date Title
GB9013410D0 (en) Polypeptide and its use
EP0406428A4 (en) Peptide derivatives and their use
ZW4090A1 (en) Composition and use
GB9121289D0 (en) Composition and use
EP0445801A3 (en) Peptide and its use
EP0482649A3 (en) Cm-chitin derivatives and use thereof
AU633294B2 (en) Motilin-like polypeptide and use thereof
GB9117954D0 (en) Multriaxis robot and use thereof
ZA893782B (en) Composition and use
ZA907336B (en) Application aid and the use thereof
EP0465132A3 (en) Dna and its use
GB9027864D0 (en) Pyrimidinyl-and triazinyl-salicylamides and their use and preparation
ZA921137B (en) Composition and use
GB9023417D0 (en) Hand and wrist support
EP0456138A3 (en) Peptide-amidase and its application
IL106436A0 (en) Synthetic polypeptides and their use
GB9016027D0 (en) Composition and use
IL105873A0 (en) Pyrimidinyl-and triazinyl-salicyl-and-picolyl-amides and the use and preparation thereof
AU8603591A (en) Peptide and its use
GB9314512D0 (en) Composition and use
ZA942246B (en) Novel imidazolo-quinoxalinones their preparation and use
EP0505941A3 (en) Peptifluorin and neopeptifluorin
ZA9057B (en) Motilin-like polypeptide and use thereof
IE900540L (en) Aminoethylthiazoles and aminoethyloxazoles
HU9300847D0 (en) Cyclolinopeptone a-analogues and their utilization

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)